File Archive - Benzodiazepines Documents - Decreased GABAA receptor subunit mRNA concentrations following chronic lorazepam administration (1991) - Drugs Forum
Drugs-Forum  
News Groups Blog Forum Chat Video Audio Images Documents Wiki Home
Go Back   Drugs Forum > File Archive > Documents > CHEMICAL & (SEMI-) SYNTHETIC DRUGS > Downers Documents > Benzodiazepines Documents
Register Tags Mark Forums Read

Notices

Search
links

 
Benzodiazepines Documents
New entries announced in forum Downers and sleeping pills
Allowances: 4.88 Mbytes/154.34 Kbytes used

  Entries
  Decreased GABAA receptor subunit mRNA concentrations following chronic lorazepam administration (1991) Left click: open entry/Right click: save entry
British Journal of Pharmacology 1991 Jun;103(2):1285-7

Kang I, Miller LG.

Chronic benzodiazepine administration has been associated with alterations in binding and function at the GABAA receptor. To evaluate effects of chronic benzodiazepine exposure on messenger RNA (mRNA) concentrations for several GABAA receptor subunits, we treated mice with lorazepam, 2 mg kg-1 daily for 1-28 days and evaluated mRNAs for the alpha 1 and gamma 2 subunits by Northern hybridization. In cerebral cortex, concentrations of mRNA for the alpha 1 and gamma 2 subunits were unchanged from vehicle or control after 1-10 days of lorazepam. However, after 14 days of treatment mRNA concentrations for both subunits decreased to approximately 50% of control values and remained decreased at 28 days. In contrast, no significant alterations were observed for either subunit mRNA in hippocampus or cerebellum over the same time course. Alterations in mRNAs in cortex occur after the development of tolerance and receptor downregulation in this model.

Discussion Thread

Category Benzodiazepines Documents 
 
Suggest other entries I might like
Submitted by Jatelka Find all entries from this user
03-05-2008
304.12 Kbytes Hits 11
Keywords: lorazepam
 

 
Category
 
Forum Jump

Sitelinks: Site Functions:

All times are GMT +1. The time now is 08:36.


Copyright: Substance Information Network 2003 - 2009, All rights reserved